Literature DB >> 12784896

Improved sleep may reduce arthritis pain.

Gail C Davis1.   

Abstract

Studies indicate that pain interferes with sleep and, in turn, sleep disturbances increase pain. Statistics show that up to 60% of those with arthritis experience pain during the night. But despite these findings, sleep is not generally addressed as a major treatment concern among this population. This article reviews the relationship between pain and sleep; sleep issues as they relate to 3 common types of arthritis--osteoarthritis, rheumatoid arthritis, and fibromyalgia; and holistic approaches that may be used by the patient in the self-management of pain and sleep.

Entities:  

Mesh:

Year:  2003        PMID: 12784896     DOI: 10.1097/00004650-200305000-00003

Source DB:  PubMed          Journal:  Holist Nurs Pract        ISSN: 0887-9311            Impact factor:   1.000


  5 in total

1.  Erratum to: Prevalence of sleep disturbance in patients with low back pain.

Authors:  Saad M Alsaadi; James H McAuley; Julia M Hush; Chris G Maher
Journal:  Eur Spine J       Date:  2012-03       Impact factor: 3.134

2.  Prevalence of sleep disturbance in patients with low back pain.

Authors:  Saad M Alsaadi; James H McAuley; Julia M Hush; Chris G Maher
Journal:  Eur Spine J       Date:  2010-12-29       Impact factor: 3.134

3.  Osteoarthritis and sleep: the Johnston County Osteoarthritis Project.

Authors:  Kelli D Allen; Jordan B Renner; Brenda Devellis; Charles G Helmick; Joanne M Jordan
Journal:  J Rheumatol       Date:  2008-05-15       Impact factor: 4.666

Review 4.  Self-efficacy and arthritis disability: An updated synthesis of the evidence base and its relevance to optimal patient care.

Authors:  Ray Marks
Journal:  Health Psychol Open       Date:  2014-12-23

5.  Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: protocol for the randomised, single-blinded, parallel-group Sleep-RA trial.

Authors:  K M Latocha; K B Løppenthin; M Østergaard; P J Jennum; R Christensen; M Hetland; H Røgind; T Lundbak; J Midtgaard; B A Esbensen
Journal:  Trials       Date:  2020-05-29       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.